Kestrel

Injection Equipment Paraphernalia

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · published Thu 22 Oct 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by The Dental Directory and Wrights Healthgroup and Henry Schein UK Holdings Limited in Sep 2026, for £13m.

What you're up against

  • The last two awards went to different firms: this buyer has changed supplier before.
  • 30 different firms won this buyer's 3 awards for this kind of work in 2026.
  • It last went for £13m in 2026.

From The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)'s earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The documents are on PCS-Tender, where the bid is sent too. It's free to register there.

The notice as published

The Common Services Agency (more commonly known as Public Services Delivery Scotland (PSDS)) (‘the authority') acting through its division Procurement, Commissioning and Facilities is undertaking this procurement of supply and delivery of Individual Items and prepacked equipment for single use for people who use drugs including performance and image enhancing drugs as defined in section 5.2 of the IEP guidance IEP-in-Scotland-GPG-SDF-PHS-Oct-2021.pdf​ and for Naloxone products for administering by approved services on behalf of all entities constituted pursuant to the National Health Service(Scotland) Act 1978 (i.e. All NHS Scotland Health Boards, Special Health Boards and the Authority of other NHS Organisation established pursuant to the NHS (Scotland) Act 1978), any integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014 (collectively hereafter referred to as 'Participating Authorities’ We require Pre-packed equipment for single use for people who use drugs including Performance and Image Enhancing Drugs as defined in section 5.2.14 of the IEP guidance IEP-in-Scotland-GPG-SDF-PHS-Oct-2021.pdf​ and as listed in the 'pack contents description' document included within the tender document pack. Innovations relating to Harm Reduction and safer drug use, for use by people who use drugs as defined in section 5.2 of the IEP guidance IEP-in-Scotland-GPG-SDF-PHS-Oct-2021.pdf in line with any advances in legislation in this regard during the lifetime of the framework. The Innovation Lot allows a supplier to highlight any products for which the framework/Lot definitions are applicable, but are not yet ready for market and thus not able to be included at time of tender, but expected to be ready for market within the lifecycle of this framework. This Lot is intended to help to streamline inclusion on the framework as soon as mandatory conditions are met. e.g. addition to guidelines Please Note: THIS IS AN UNSCORED LOT. Bidders to this lot will have to be awarded to one or more of lots 1-3 on this framework to be awarded to this lot. We require all relevant individual items to be issued to people who use drugs. Paraphernalia to include, but not limited to – needles, syringes, foil, water for injection, pre-injection wipes, Citric Acid, Ascorbic Acid, filters, sharps containers and spoons, hand hygiene wipes, as defined by the IEP Guidance for Scotland for 2021. The combination Lot allows a supplier to make any reasonable offer of a discounted pricing structure to NHS boards, in return for value or volume commitment in sum, in part, or in collaboration with other geographically local boards, for an agreed time period. NHS National Procurement supports any suppliers commitment deals through promoting offers available via internal documents to all NHS boards. Suppliers reserve the right to amend previously agreed offers, if the board-committed value or volumes over agreed time fall short. Please Note: THIS IS AN UNSCORED LOT. Bidders to this lot will have to be awarded to one or more of lots 1-3 on this framework to be awarded to this lot. NHS Scotland requires compliant to Government guidelines injection and/or nasal spray Naloxone products as follows: - Naloxone Hydrochloride 1 mg/ml PFS (2ml) licenced for use by individuals in the community, such as Prenoxad, or equivalent. - Naloxone 1.8 mg nasal spray, solution in a single-dose container licenced for use by individuals in the community, such as Nyxoid, or equivalent.